Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
3.
Mol Imaging Biol ; 12(4): 443-51, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19921339

ABSTRACT

PURPOSE: We evaluated whether 18F-FDG-PET altered stage classification, management, and prognostic stratification of newly diagnosed small cell lung cancer (SCLC). PROCEDURES: We identified 46 consecutive patients undergoing staging positron emission tomography for SCLC from 1993-2008 inclusive. Updated survival data from the state Cancer Registry was available on 42 of 46 patients. RESULTS: PET altered stage classification in 12 of 46 (26%) patients. PET altered treatment modality in nine patients, and the target mediastinal radiation field in another three patients. Therefore, PET altered management in 12 of 46 (26%) patients. Patients with limited disease (LD) on pre-PET staging had significantly longer overall survival (OS) than those upstaged to extensive disease (ED; median 18.6 months versus 5.7 months; log-rank p < 0.0001). In patients with ED on pre-PET staging, those downstaged to LD by PET had significantly longer OS than those with ED on PET (median 10.9 months versus 5.9 months; log-rank p = 0.037). CONCLUSION: PET had a major impact on stage classification, management, and prognostic stratification of newly diagnosed SCLC.


Subject(s)
Fluorodeoxyglucose F18 , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/therapy , Positron-Emission Tomography , Small Cell Lung Carcinoma/diagnostic imaging , Small Cell Lung Carcinoma/therapy , Aged , Female , Humans , Kaplan-Meier Estimate , Lung Neoplasms/pathology , Male , Neoplasm Staging , Prognosis , Proportional Hazards Models , Small Cell Lung Carcinoma/pathology , Tomography, X-Ray Computed
4.
Epileptic Disord ; 10(4): 362-70, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19017581

ABSTRACT

Patients with multifocal epilepsy are often considered unsuitable for epilepsy surgery. We report an adolescent with intractable frontal and occipital lobe seizures, secondary to complications of treatment for acute lymphoblastic leukaemia as a young child. Chemotherapy and radiotherapy were complicated by bilateral, posterior leukoencephalopathy and later an acquired frontal cerebral cavernous malformation (CCM). Detailed electro-clinical and imaging studies showed multiple, frontal lobe seizures per day with less frequent and non-debilitating, simple, occipital lobe seizures. Focal resection of the frontal CCM abolished the socially-disabling seizures with resultant marked improvement in the patient's quality of life at 12 months. Careful analysis of the type and impact of focal seizures in the setting of multifocal epilepsy may demonstrate that one seizure type is more deleterious to quality of life and may be amenable to surgery. In this situation, the patient may benefit significantly from surgery to resect the more active epileptic focus.


Subject(s)
Epilepsies, Partial/etiology , Epilepsies, Partial/surgery , Epilepsy, Frontal Lobe/surgery , Neurosurgical Procedures , Occipital Lobe , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy , Radiotherapy/adverse effects , Adolescent , Antineoplastic Agents/adverse effects , Central Nervous System Vascular Malformations/pathology , Electroencephalography , Epilepsies, Partial/diagnostic imaging , Epilepsy, Frontal Lobe/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Occipital Lobe/diagnostic imaging , Occipital Lobe/surgery , Palliative Care , Quality of Life , Social Behavior , Tomography, Emission-Computed, Single-Photon
5.
J Nucl Med ; 48(4): 547-52, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17401090

ABSTRACT

UNLABELLED: Amyloid-beta (Abeta) imaging with N-methyl-(11)C-2-(4'-methylamino-phenyl)-6-hydroxy-benzothiazole ((11)C-6-OH-BTA-1; also known as (11)C-PIB) shows a robust increase in cortical binding in Alzheimer's disease (AD). The aim of this study was to explore the clinical potential of Abeta imaging for the diagnosis of AD by comparison of the accuracy of visual reading of (11)C-PIB images with quantitative analysis and (18)F-FDG. METHODS: Fifteen AD patients (age, 71.1 +/- 11.3 y [mean +/- SD]; mini-mental state examination [MMSE], 18.9 +/- 9.3 [mean +/- SD]) and 25 healthy control (HC) subjects (age, 71.9 +/- 6.82 y; MMSE >or= 28) underwent 90-min dynamic (11)C-PIB PET and 20-min static (18)F-FDG PET. (11)C-PIB images, generated from data acquired between 40 and 70 min after injection, and (18)F-FDG images were rated separately by 2 readers as normal, possible AD, or probable AD. Quantitative analyses used the distribution volume ratio (DVR) of frontal cortex, parietotemporal cortex, posterior cingulate, and caudate nucleus for (11)C-PIB and standardized uptake value ratio (SUVR) of parietotemporal cortex and posterior cingulate for (18)F-FDG, using cerebellar cortex as the reference region. Receiver-operating-characteristic (ROC) analysis was performed to compare the accuracy of quantitative measures. To determine the effect of age on diagnostic accuracy, the median age of the AD subjects (74 y) was chosen to separate the cohort into younger (64.4 +/- 5.8 y) and older (78.6 +/- 4.1 y) groups. RESULTS: Visual agreement between readers was excellent for (11)C-PIB (kappa = 0.90) and good for (18)F-FDG (kappa = 0.56). (11)C-PIB was more accurate than (18)F-FDG both on visual reading (accuracy, 90% vs. 70%, P = 0.05) and ROC analysis (95% vs. 83%, P = 0.02). Accuracy declined more with (18)F-FDG than with (11)C-PIB in the older group. CONCLUSION: Visual analysis of (11)C-PIB images appears more accurate than visual reading of (18)F-FDG for identification of AD and has accuracy similar to quantitative analysis of a 90-min dynamic scan. The accuracy of (11)C-PIB PET is limited by cortical binding in some healthy elderly subjects, consistent with postmortem studies of cerebral Abeta. Longitudinal follow-up is required to determine if this represents detection of preclinical AD.


Subject(s)
Alzheimer Disease/diagnosis , Alzheimer Disease/pathology , Benzothiazoles/pharmacokinetics , Brain/pathology , Carbon Radioisotopes/pharmacokinetics , Fluorodeoxyglucose F18/pharmacokinetics , Image Processing, Computer-Assisted , Aged , Aniline Compounds , Cohort Studies , Female , Humans , Male , Middle Aged , Models, Statistical , Observer Variation , ROC Curve , Thiazoles
6.
J Nucl Med Technol ; 33(1): 44-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15731021

ABSTRACT

OBJECTIVE: The use of PET in Australia has grown rapidly. We conducted a prospective study of the radiation exposure of technologists working in PET and evaluated the occupational radiation dose after implementation of strategies to lower exposure. METHODS: Radiation doses measured by thermoluminescent dosimeters over a 2-y period were reviewed both for technologists working in PET and for technologists working in general nuclear medicine in a busy academic nuclear medicine department. The separate components of the procedures for dose administration and patient monitoring were assessed to identify the areas contributing the most to the dose received. The impact on dose of implementing portable 511-keV syringe shields (primary shields) and larger trolley-mounted shields (secondary shields) was also compared with initial results using no shield. RESULTS: We found that the radiation exposure of PET technologists was higher than that of technologists performing general nuclear medicine studies, with doses averaging 771 +/- 147 and 524 +/- 123 microSv per quarter, respectively (P = 0.01). The estimated dose per PET procedure was 4.1 microSv (11 nSv/MBq). Injection of 18F-FDG contributed the most to radiation exposure. The 511-keV syringe shield reduced the average dose per injection from 2.5 to 1.4 microSv (P < 0.001). For the longer period of dose transportation and injection, the additional use of the secondary shield resulted in a significantly lower dose of radiation than did use of the primary shield alone or no shield (1.9 vs. 3.6 microSv [P = 0.01] and 3.4 microSv [P = 0.03], respectively). CONCLUSION: The radiation doses currently received by technologists working in PET are within accepted occupational health guidelines, but improved shielding can further reduce the dose.


Subject(s)
Nuclear Medicine Department, Hospital/statistics & numerical data , Occupational Exposure/prevention & control , Occupational Exposure/statistics & numerical data , Positron-Emission Tomography/statistics & numerical data , Radiation Monitoring/methods , Radiation Protection/methods , Risk Assessment/methods , Australia/epidemiology , Humans , Occupational Exposure/analysis , Radiation Dosage , Radiation Injuries/prevention & control , Risk Factors , Thermoluminescent Dosimetry/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...